Prospective Study of Colon Serrated Polyps
NCT02332785 is an observational study sponsored by M.D. Anderson Cancer Center. As of 21 Nov 2026, it is recruiting participants. It studies Colon Polyps. The registry lists an enrollment of 10,000 participants at 1 site in 1 country. The registry lists a start date of 30 Nov 2014 and a primary completion date of 30 Nov 2026.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT02332785 |
| Status | Recruiting |
| Study type | Observational study |
| Lead sponsor | M.D. Anderson Cancer Center |
| Enrollment | 10,000 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Colon Polyps |
| Start | 30 Nov 2014 |
| Primary completion | 30 Nov 2026 |
| Study completion | 30 Nov 2027 |
| Last update posted | 14 May 2019 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Gottumukkala S. Raju, MD
M.D. Anderson Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Texas Md Anderson Cancer Center
Houston
Recruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT02332785
Each answer restates registry values shown on this page.
What is NCT02332785?
NCT02332785 is an observational study sponsored by M.D. Anderson Cancer Center. It studies Colon Polyps.
Is NCT02332785 recruiting?
As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.
Who leads NCT02332785?
The registry names Gottumukkala S. Raju, MD (principal investigator, M.D. Anderson Cancer Center) as the overall official.
Where does NCT02332785 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT02332785 expected to complete?
The registry lists a primary completion date of 30 Nov 2026 and a study completion date of 30 Nov 2027. The sponsor last updated the record on 14 May 2019.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.